Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Ratings
Axsome Therapeutics: Strategic Developments and Market Exclusivity Drive Buy Rating
6d ago
AXSM
Premium
The Fly
Axsome Therapeutics management to meet with Piper Sandler
7d ago
AXSM
Premium
The Fly
Axsome Therapeutics settles Sunosi patent litigation with Hikma
7d ago
AXSM
Premium
Ratings
Positive Outlook for Axsome Therapeutics Amid sNDA Progress and Strategic Pricing
8d ago
AXSM
Premium
Ratings
Axsome Therapeutics: Promising Regulatory Progress and Market Potential Justify Buy Rating
8d ago
AXSM
Premium
Ratings
Axsome Therapeutics’ AXS-05: Promising Regulatory Progress and Strategic Positioning for Market Success
9d ago
AXSM
Premium
Ratings
Positive FDA Feedback and Strategic Moves Bolster Axsome Therapeutics’ Buy Rating
9d ago
AXSM
Premium
The Fly
Axsome Therapeutics expects to submit sNDA for AXS-05 in Q3
9d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $160 from $132 at Baird
9d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $190 from $125 at Morgan Stanley
13d ago
AXSM
Premium
Ratings
Axsome Therapeutics: Strategic Advancements and Market Positioning Drive Buy Rating
13d ago
AXSM
Premium
Ratings
Positive Outlook for Axsome Therapeutics Driven by Symbravo’s Promising Study Results and Market Potential
13d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $212 from $195 at Mizuho
14d ago
AXSM
Premium
Ratings
Buy Rating for Axsome Therapeutics Driven by Promising SYMBRAVO Phase 3 Trial Results
15d ago
AXSM
Premium
Ratings
Axsome Therapeutics’ Symbravo: A Promising Alternative in the Migraine Treatment Market
16d ago
AXSM
Premium
The Fly
Axsome Therapeutics says SYMBRAVO achieves primary endpoint in EMERGE trial
16d ago
AXSM
Premium
Ratings
Optimistic Long-Term Prospects for Axsome Therapeutics Amid Strong Sales and Strategic Pipeline Developments
19d ago
AXSM
Premium
Ratings
Axsome Therapeutics: Strong Commercial Performance and Strategic Growth Initiatives Drive Buy Rating
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $200 from $190 at H.C. Wainwright
20d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $200 from $190 at Truist
21d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $192 from $143 at RBC Capital
21d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $153 from $133 at Needham
21d ago
AXSM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
